We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site. To find out more, including how to change your settings, see our Cookie Policy

Dec 22 | EGX continues to close trading in the green zone

Market capitalization gained around LE 7.54 billion, recording LE 742.43 billion, compared to LE 734.89 billion in Tuesday’s session

By: Business Today Egypt

Wed, Dec. 22, 2021

Maintaining yesterday’s incline, the Egyptian Exchange (EGX) closed Wednesday’s trading in the green zone, adding around LE 7.54  billion to market capitalization, amid Egyptian and Arab purchases.

The benchmark EGX30 hiked 0.92 percent, or 105.97 points, to end at 11,630.63 points.

The equally weighted index EGX 50 jumped 1.35 percent, or 27.33 points, to end at 2,049.88 points.

The small and mid-cap index EGX 70 increased 1.19 percent, or 25.44 points, to close at 2,172.05 points, and the broader index EGX100 climbed 1.16 percent, or 36.71 points, to close at 3,203.41 points.

Market capitalization gained around LE 7.54 billion, recording LE 742.43 billion, compared to LE  734.89 billion in Tuesday’s session.

The trading volume reached 325.67 million shares, traded through 42,121 transactions, with a turnover of LE 1.09 billion.

Foreign investors were net sellers at LE 64.35 million, while Egyptian and Arab investors were net buyers at LE 19.15 million, and LE 45.2 million, respectively.

Egyptian and foreign individuals were net sellers at LE 87.75 million, and LE 1 million, respectively, while Arab individuals were net buyers at LE 51.32 million.

Arab and foreign organizations sold at LE 6.12 million, and LE 63.35 million, respectively, while Egyptian organizations bought at LE 106.9 million.

Misr Hotels, Grand Investment Capital, and October Pharma, were top gainers of the session at 10.61 percent, 7.76 percent and 7.27 percent, respectively.

Meanwhile, Alexandria Pharmaceuticals, Tenth Of Ramadan Pharmaceutical Industries & Diagnostic- Rameda, and GlaxoSmithKline were top losers of the session by 20 percent, 3.24 percent, and 3.07 percent, respectively.